Related Experiment Videos
The DNA methylation machinery as a target for anticancer therapy
1Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Pharmacology & Therapeutics
|January 1, 1996
Summary
DNA methylation regulates genome functions and is altered in cancer. DNA methyltransferase (MeTase) inhibitors show potential as therapeutic tools for cancer and genetic diseases.
Area of Science:
- Epigenetics and Molecular Biology
- Cancer Biology
- Pharmacology
Background:
- DNA methylation is a key epigenetic mechanism regulating gene expression, replication, and cellular processes.
- Aberrant DNA methylation patterns are implicated in the development of cancer.
- DNA methyltransferase (MeTase) activity is a critical factor in establishing and maintaining methylation patterns.
Purpose of the Study:
- To explore the pharmacological implications of understanding DNA methylation patterns.
- To review the therapeutic potential of DNA methyltransferase inhibitors in cancer and genetic diseases.
Main Methods:
- Literature review focusing on DNA methylation, DNA methyltransferase activity, and cancer.
- Analysis of current research on oncogenic pathways and their effect on DNA MeTase.
- Evaluation of studies investigating the role of DNA MeTase inhibition in reversing cancer phenotypes.
Main Results:
- Elevated DNA methyltransferase activity is observed in various cancers.
- Inhibition of DNA methyltransferase has demonstrated the potential to reverse the transformed state in cancer cells.
- Oncogenic pathways can influence the expression of DNA methyltransferase.
Conclusions:
- DNA methyltransferase inhibitors represent a promising class of pharmacological agents.
- Targeting DNA methylation offers a potential therapeutic strategy for cancer treatment.
- Further research into DNA methyltransferase inhibitors could yield novel treatments for genetic diseases.